Does OCRELIZUMAB Cause Musculoskeletal stiffness? 502 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 502 reports of Musculoskeletal stiffness have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.9% of all adverse event reports for OCRELIZUMAB.
502
Reports of Musculoskeletal stiffness with OCRELIZUMAB
0.9%
of all OCRELIZUMAB reports
3
Deaths
155
Hospitalizations
How Dangerous Is Musculoskeletal stiffness From OCRELIZUMAB?
Of the 502 reports, 3 (0.6%) resulted in death, 155 (30.9%) required hospitalization, and 4 (0.8%) were considered life-threatening.
Is Musculoskeletal stiffness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 502 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Musculoskeletal stiffness?
ADALIMUMAB (10,762)
METHOTREXATE (9,903)
ETANERCEPT (9,744)
TOFACITINIB (7,354)
TOCILIZUMAB (6,346)
RITUXIMAB (6,058)
LEFLUNOMIDE (6,031)
ABATACEPT (5,926)
SECUKINUMAB (5,655)
HYDROXYCHLOROQUINE (5,271)
Which OCRELIZUMAB Alternatives Have Lower Musculoskeletal stiffness Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE